Advanced Enzyme Technologies Limited — JV/Acquisition, 08-08-2026: Acquisition

Advanced Enzyme Technologies is acquiring the remaining 4.28% stake in its subsidiary, JC Biotech Private Limited (JCB), for a total consideration of ₹7.98 Cr. This strategic move will make JCB, a key manufacturer of bio-pharmaceuticals through aerobic fermentation with FY26 turnover of ₹72.8 Cr, a wholly-owned subsidiary. The acquisition aims to optimize synergies across business operations, strengthening the company's position in its core segments.